UB Paderborn / Katalog / Suche / in CDI

Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial

The lancet oncology, 2015-10, Vol.16 (13), p.1355-1369

2015

Volltextzugriff (PDF)

Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch® System and the AdnaTest

PloS one, 2016-05, Vol.11 (5), p.e0155126-e0155126

2016

Volltextzugriff (PDF)

Treatment approach in patients with hyperbilirubinemia secondary to liver metastases in gastrointestinal malignancies: a case series and review of literature

Therapeutic advances in medical oncology, 2016-05, Vol.8 (3), p.144-152

2016

Volltextzugriff (PDF)

Immobilization in internal or external rotation does not change recurrence rates after traumatic anterior shoulder dislocation

Journal of shoulder and elbow surgery, 2014, Vol.23 (1), p.13-19

2014

Volltextzugriff (PDF)

Fundamentals of Clinical Outcomes Assessment for Spinal Disorders: Clinical Outcome Instruments and Applications

Global Spine Journal, 2015-08, Vol.5 (4), p.329-338

2015

Volltextzugriff (PDF)

Regorafenib with TAS-102 (REGOTAS) in metastatic colorectal cancer patients who progressed after at least two standard therapies: Efficacy and safety results of a multicenter phase I study (REMETY)

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.158-158

2020

Volltextzugriff (PDF)

T‐cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker

International journal of cancer, 2017-06, Vol.140 (11), p.2535-2544

2017

Volltextzugriff (PDF)

Emotionale und andere Belastungen bei Krebsüberlebenden

InFo Onkologie, 2017-10, Vol.20 (6), p.22-24

Quidde, Julia

2017

Volltextzugriff (PDF)

Improved Nutrition in Adolescents and Young Adults after childhood cancer: INAYA—A pilot study

Journal of clinical oncology, 2016-01, Vol.34 (3_suppl), p.173-173

2016

Volltextzugriff (PDF)

Improved detection of circulating tumor cells in metastatic colorectal cancer by the combination of the cellsearch.sup.® system and the adnatest.sup.

PloS one, 2016-05, Vol.11 (5)

2016

Volltextzugriff (PDF)

Treatment of Metastatic Spindle Epithelial Tumor with Thymus-Like Differentiation (SETTLE) - Long-Term Disease Control by Multimodal Therapy

Oncology research and treatment, 2018-01, Vol.41 (1-2), p.56-58

2018

Volltextzugriff (PDF)

Abstract 5693: Low coverage genome-wide sequencing of cell-free DNA enables detection, therapeutic monitoring, and characterization of copy number alterations in patients with solid tumors

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5693-5693

2017

Volltextzugriff (PDF)

T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker: TCR diversification in checkpoint inhibition

International journal of cancer, 2017-06, Vol.140 (11), p.2535-2544

2017

Volltextzugriff (PDF)

AIO LQ-0110: a randomized phase II trial comparing oral doxycycline versus local administration of erythromycin as preemptive treatment strategies of panitumumab-mediated skin toxicity in patients with metastatic colorectal cancer

Oncotarget, 2017-12, Vol.8 (62), p.105061-105071

2017

Volltextzugriff (PDF)

Impact of FOLFOXIRI and bevacizumab (bev) compared to FOLFOX and bev on health related quality of life (HRQOL) in patients with metastatic colorectal cancer (MCRC): Analysis of the CHARTA-AIO 0209 trial

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.3544-3544

2017

Volltextzugriff (PDF)

Baseline and On-Treatment Markers Determining Prognosis of First-Line Chemotherapy in Combination with Bevacizumab in Patients with Metastatic Colorectal Cancer

Oncology research and treatment, 2017, Vol.40 (1-2), p.21-26

2017

Volltextzugriff (PDF)

Changing symptom burden in cancer patients: Does physician-patient communication cover physical, psychological and social discomfort? A Survey among 2009 German patients

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e17717-e17717

2015

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial

Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch® System and the AdnaTest

Treatment approach in patients with hyperbilirubinemia secondary to liver metastases in gastrointestinal malignancies: a case series and review of literature

Immobilization in internal or external rotation does not change recurrence rates after traumatic anterior shoulder dislocation

Fundamentals of Clinical Outcomes Assessment for Spinal Disorders: Clinical Outcome Instruments and Applications

Regorafenib with TAS-102 (REGOTAS) in metastatic colorectal cancer patients who progressed after at least two standard therapies: Efficacy and safety results of a multicenter phase I study (REMETY)

T‐cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker

Emotionale und andere Belastungen bei Krebsüberlebenden

Improved Nutrition in Adolescents and Young Adults after childhood cancer: INAYA—A pilot study

Improved detection of circulating tumor cells in metastatic colorectal cancer by the combination of the cellsearch.sup.® system and the adnatest.sup.

Treatment of Metastatic Spindle Epithelial Tumor with Thymus-Like Differentiation (SETTLE) - Long-Term Disease Control by Multimodal Therapy

Abstract 5693: Low coverage genome-wide sequencing of cell-free DNA enables detection, therapeutic monitoring, and characterization of copy number alterations in patients with solid tumors

T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker: TCR diversification in checkpoint inhibition

AIO LQ-0110: a randomized phase II trial comparing oral doxycycline versus local administration of erythromycin as preemptive treatment strategies of panitumumab-mediated skin toxicity in patients with metastatic colorectal cancer

Impact of FOLFOXIRI and bevacizumab (bev) compared to FOLFOX and bev on health related quality of life (HRQOL) in patients with metastatic colorectal cancer (MCRC): Analysis of the CHARTA-AIO 0209 trial

Baseline and On-Treatment Markers Determining Prognosis of First-Line Chemotherapy in Combination with Bevacizumab in Patients with Metastatic Colorectal Cancer

Changing symptom burden in cancer patients: Does physician-patient communication cover physical, psychological and social discomfort? A Survey among 2009 German patients

Aktive Filter

Suchergebnisse filtern